Satellos Bioscience (TSX:MSCL) Ending Cash Position : C$13.11 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Satellos Bioscience Ending Cash Position?

Satellos Bioscience's Ending Cash Position for the quarter that ended in Mar. 2024 was C$13.11 Mil.

Satellos Bioscience's quarterly Ending Cash Position declined from Sep. 2023 (C$44.26 Mil) to Dec. 2023 (C$22.07 Mil) and declined from Dec. 2023 (C$22.07 Mil) to Mar. 2024 (C$13.11 Mil).

Satellos Bioscience's annual Ending Cash Position declined from Dec. 2021 (C$4.87 Mil) to Dec. 2022 (C$1.92 Mil) but then increased from Dec. 2022 (C$1.92 Mil) to Dec. 2023 (C$22.07 Mil).

Satellos Bioscience Ending Cash Position Historical Data

The historical data trend for Satellos Bioscience's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Satellos Bioscience Ending Cash Position Chart

Satellos Bioscience Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

0.72

4.87

1.92

22.07

Satellos Bioscience Quarterly Data
	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial										2.98	48.73	44.26	22.07	13.11

Satellos Bioscience Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Satellos Bioscience's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1.924	+	20.143
	=	22.07

Satellos Bioscience's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	22.067	+	-8.953
	=	13.11

Satellos Bioscience Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Satellos Bioscience's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Satellos Bioscience (TSX:MSCL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Satellos Bioscience Inc (TSX:MSCL) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

MSCLF:USA 0IT:Germany

Address

65 Front Street East, Suite 201, Toronto, ON, CAN, M5E 1B5

Website

https://www.satellos.com

Satellos Bioscience Inc is a regenerative medicine company dedicated to developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. Its lead program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.

Satellos Bioscience (TSX:MSCL) Headlines

No Headlines